7. So, although the etiology of
thrombophlebitis in PPN is often
multifactorial, the osmolarity of the
infused PPN solution may be an
important variable.
8.
To decrease the likelihood of phlebitis, the
osmolarity of PPN should be between
600 and 900 mOsm.
9. For solutions with an osmolarity of
1100 mOsm or greater, lipid
emulsion may be added to increase the
patient's tolerance for the infusion. However,
this approach is not recommended for patients
with contraindications,
such as
13.
Addition of heparin to PN solutions “reduces the
formation of a fibrin sheath around the catheter,
may
reduce phlebitis… and increases the duration of
catheter patency” (Groh-Wargo, et al., 2000).
Heparin also
stimulates the release of lipoprotein lipase,
which may improve lipid clearance.
14.
This approach may not be appropriate for
all types of patients. For example, heparin
should be avoided in patients with a
history of heparin-induced
thrombocytopenia. In addition,
hydrocortisone and heparin may not be
stable additives for all PPN solutions,
especially those containing fat emulsion.
19. Because of the limitations in osmolarity of
PPN solutions, the typical PPN composition
provides a final concentration of amino acids
that is generally between 2.5%
and 5% (50 g/L). Dextrose
concentrations
(25 g/L)
The application of a nitroglycerin patch and the topical administration of nonsteroidal anti-inflammatory drug gels near the line insertion site are approaches that are sometimes used to prevent phlebitis, but their routine use is not recommended at this time.[1,3] However, studies evaluating these approaches enrolled small patient numbers[4] and did not include a placebo control,[5] or were not done specifically with patients on PPN,[6] so the data are not sufficient to support routine use.